Overweight and Obesity Prevalence Higher in Less Walkable Neighborhoods
The adjusted prevalence of overweight and obesity was lower in the highest walkable areas compared to the lowest (43.3% vs 53.5%).
The adjusted prevalence of overweight and obesity was lower in the highest walkable areas compared to the lowest (43.3% vs 53.5%).
For diabetes patients with low-density lipoprotein cholesterol levels 2.5 mmol/L.
After 3 months of air pollution exposure, researchers found individuals had higher blood glucose levels, higher levels of low-density lipoprotein and triglycerides, and lower levels of high-density lipoprotein cholesterol.
Patients with rapid decline in estimated glomerular filtration rate had adjusted risk of major adverse cardiovascular events that was 4.11 times higher.
Treatment with sulfonylureas may inhibit the neuroprotective effects of KATP channel activation and increase stroke risk in patients with diabetes.
Percutaneous coronary intervention use has increased among patients with diabetes and multivessel coronary artery disease who present with non-ST-segment elevation myocardial infarction.
Compared with nonuse, current SSRI use correlated with increased 30-day stroke mortality (adjusted mortality rate ratio: 1.3), with the highest risk for new users.
Individuals who carried the most favorable adiposity alleles had higher body mass indexes and body fat percentages.
All age groups had significant decreases in all-cause, cardiovascular disease, and diabetes mortality rates except for diabetes mortality in younger individuals (ages 0 to 40).
The risk for obesity was greater among those with psoriasis—11.6% of people with psoriasis were obese, but only 8.1% of non-obese individuals had psoriasis.